Glenmede Trust’s ProShares Ultra Technology ROM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,800
Closed -$298K 2566
2020
Q2
$298K Buy
+12,800
New +$245K ﹤0.01% 909
2019
Q4
Sell
-64
Closed 3110
2019
Q3
$0 Sell
64
-11,936
-99% -$184K ﹤0.01% 3098
2019
Q2
$176 Sell
12,000
-12,000
-50% -$174K ﹤0.01% 1202
2019
Q1
$331 Hold
24,000
﹤0.01% 1008
2018
Q4
$236 Buy
+24,000
New +$285K ﹤0.01% 1059
2018
Q3
Sell
-24,000
Closed -$308K 1763
2018
Q2
$308K Hold
24,000
﹤0.01% 947
2018
Q1
$263K Hold
24,000
﹤0.01% 1099
2017
Q4
$263K Sell
24,000
-1,600
-6% -$17.1K ﹤0.01% 1099
2017
Q3
$239K Buy
+25,600
New +$229K ﹤0.01% 1164

Other funds holding ROM

Glenmede Trust's ROM Position: Q3 2020 in Review

Glenmede Trust sold out of ProShares Ultra Technology (ROM) in Q3 2020, closing a stake of 12,800 shares — an estimated $298K sold.

Glenmede Trust first reported a position in ROM in Q3 2017 and held it in 9 quarters. The position peaked at $308K in Q2 2018. 47 funds tracked by Wall St. Rank hold ROM as of Q3 2020.

  • Glenmede Trust reported no remaining ProShares Ultra Technology position as of Q3 2020 after selling out during the quarter.
  • Glenmede Trust sold 12,800 ProShares Ultra Technology shares in Q3 2020, an estimated $298K.
  • Glenmede Trust first reported a position in ProShares Ultra Technology in Q3 2017 and held it in 9 quarters.
  • Glenmede Trust's ProShares Ultra Technology position peaked at $308K in Q2 2018.
  • 47 funds tracked by Wall St. Rank held ProShares Ultra Technology as of Q3 2020.

Based on Glenmede Trust's 13F filing for Q3 2020, filed 16 Nov 2020.